Philippine Health Research Registry
Display Options
Results List
Results 1 - 7 of 7 research(es) registered in February 2018

Show: All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

#
Study
         
Project Status:
Pending
Project Description:
This study is a single-blind, multi-center, randomized, active-controlled, parallel group, phase II study designed to evaluate the safety and immunogenicity of LBVE compared with Prevnar13 given with 3 doses vaccinations in healthy infants.
Project Status:
Ongoing
Project Description:
This is a multicenter, multinational, double-blind, 1:1 randomized, parallel-group, equivalence Phase 3 study to compare the efficacy and safety of MB02 plus chemotherapy (carboplatin and paclitaxel) versus Avastin® plus chemotherapy (carboplatin and paclitaxel) in subjects with Stage IIIB/IV non-squamous NSCLC. MB02/Avastin® plus chemot... [read more]
Project Status:
Ongoing
Project Description:
This will be a Phase IIb, randomized, double-blind, placebo-controlled multicenter study. Study patients will be enrolled into one of the two treatment groups and allocated in a 1:1 randomization ratio to receive IFN-K or placebo as outlined below:  Group 1: IFN-K emulsified in ISA 51 VG  Group 2: placebo emulsified in ISA 51 VG A total of 17... [read more]
Project Status:
Ongoing
Project Description:
This is a randomised, double-blind, parallel group, placebo-controlled study designed to evaluate the efficacy and safety of a fixed 30 mg dose of benralizumab administered subcutaneously (SC) for patients with a history of asthma exacerbations and uncontrolled asthma receiving medium to high-dose inhaled corticosteroid plus long-acting β2-agonist... [read more]
Project Status:
Ongoing
Project Description:
This study is a 2-treatment period, randomized, multicenter parallel-group safety study (Figure 3-1). Treatment Period 1 is a 52-week, double-blind treatment period in which QAW039 or placebo is added to GINA steps 3, 4 and 5 SoC asthma therapy. Treatment Period 2 is an optional 104-week, single-blind treatment period in which patients will receive... [read more]
Project Status:
Ongoing
Project Description:
This extended access study will assess the long-term safety and tolerability of bardoxolone methyl in qualified patients with pulmonary hypertension (PH) who previously participated in controlled clinical studies with bardoxolone methyl. Qualified patients will receive 10 mg of bardoxolone methyl once daily until the drug is available through co... [read more]
Project Status:
Ongoing
Project Description:
For this research, Siquijor State College endeavor to conduct a follow-up study on the folk healing practices of the local healers in the areas of Senora River in Lazi municipality focusing on the healers who have used not only the plants from the mountains of Mt. Bandilaan. It will document other materials used in folk healing aside from plants su... [read more]